Plain-English translation of NCT07708350 on ClinicalTrials.gov โ ยท Source last updated ยท How we translate trials
Read our Sickle Cell Disease research guide โPhase 1 โ Testing in a small group (usually 20โ80 people) to find a safe dose and watch for side effects.
United States
Phase
Safety & dosing
Sponsor
Daniel Bauer
Enrollment target
~5 participants
Started
August 2026
Primary completion
December 2028
Age range
13 Years โ 40 Years
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Emily Morris
Daniel Bauer
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.